HUMASIS CO., LTD. Logo

HUMASIS CO., LTD.

Develops & manufactures rapid in-vitro diagnostic test kits & instruments for global POCT markets.

205470 | KO

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
South Korea
Address:
경기도 안양시 동안구 전파로 88 신원비젼타워 114호.502호.504호.604호.604-1호.비03-1호.비03-2호, 안양시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

HUMASIS CO., LTD. is a company specializing in the research, development, and manufacturing of in-vitro diagnostic (IVD) medical devices. Since its establishment in 2000, the firm has concentrated on Point-of-Care Testing (POCT) solutions, delivering rapid and accurate diagnostic results. Its product portfolio includes a wide range of immunodiagnostic rapid test kits for the early screening of conditions such as infectious diseases, cardiac markers, and tumor markers. A key aspect of its strategy is the in-house development and production of core bio-materials, such as diagnostic antigens, to ensure the quality and accuracy of its kits. The company also provides compact diagnostic instruments for quantitative analysis. Humasis serves a global market, exporting its products to numerous countries with the goal of empowering individuals through accessible self-health management tools.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for HUMASIS CO., LTD. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all HUMASIS CO., LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for HUMASIS CO., LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Hana Pharm. Co., Ltd. Logo
Pharmaceutical firm specializing in anesthetics and narcotic analgesics for global markets.
South Korea 293480
Hanmi Pharm. Co., Ltd. Logo
Biopharma firm developing innovative diabetes and cancer drugs for patients and professionals.
South Korea 128940
Hansa Biopharma Logo
Develops antibody-cleaving enzymes to treat rare diseases and enable organ transplants.
Sweden HNSA
HEALIOS K.K. Logo
Develops iPS and somatic stem cell therapies for diseases like ARDS and cancer.
Japan 4593
Heartseed株式会社 Logo
Develops iPSC-derived cell therapies to regenerate heart tissue for heart failure.
Japan 219A
HELLENIC DYNAMICS PLC Logo
Cultivates and supplies THC-dominant medical cannabis for the European pharmaceutical market.
United Kingdom HELD
HEMOGENYX PHARMACEUTICALS PLC Logo
Develops CAR-T therapies for blood cancers, autoimmune disorders, and viral infections.
United Kingdom HEMO
HEM Pharma Inc. Logo
Microbiome biotech using analysis for personalized probiotics, LBPs, and full CDMO services.
South Korea 376270
Hemp Health Spolka Akcyjna Logo
A vertically integrated supplier of medical cannabis raw material for the Polish market.
Poland HMP
Herantis Pharma Oyj Logo
Developing disease-modifying therapies for neurodegenerative conditions like Parkinson's disease.
Finland HRTIS

Talk to a Data Expert

Have a question? We'll get back to you promptly.